Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.250
+0.070 (3.21%)
At close: Jun 17, 2026, 4:00 PM EDT
2.300
+0.050 (2.22%)
After-hours: Jun 17, 2026, 7:42 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $405.8 million as of June 17, 2026. Its market cap has increased by 726.15% in one year.
Market Cap
405.80M
Enterprise Value
319.02M
1-Year Change
726.15%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $405.80M, a decrease of -61.39%. That is a compound annual growth rate of -17.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 405.80M | 367.19% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 417.67M |
| Prelude Therapeutics | 416.55M |
| Adlai Nortye | 402.00M |
| vTv Therapeutics | 400.08M |
| Ocugen | 399.46M |
| Autolus Therapeutics | 396.55M |
| Eupraxia Pharmaceuticals | 393.20M |
| Sagimet Biosciences | 389.04M |